Sun Wenlong, Zhuang Chunlin, Li Xia, Zhang Bowei, Lu Xinhua, Zheng Zhihui, Dong Yuesheng
School of Life Science, Biotechnology, Dalian University of Technology, Dalian, Liaoning 116024, China.
School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China.
Bioorg Med Chem Lett. 2017 Aug 1;27(15):3382-3385. doi: 10.1016/j.bmcl.2017.06.001. Epub 2017 Jun 19.
Protein tyrosine phosphatase 1B (PTP1B) inhibitors as potential therapies for diabetes and obesity have attracted much attention in recent years. Six varic acid analogues were isolated from two strains of fungi and evaluated for PTP1B inhibition activities. The structure-activity relationships were also characterized and predicted by molecular modeling. Further kinetic studies indicated the reversible and competitive inhibition manner of varic acid analogues. Trivaric acid showed insulin-sensitizing effect not only in vitro but also in vivo, representing a promising lead compound for further optimization.
近年来,蛋白酪氨酸磷酸酶1B(PTP1B)抑制剂作为治疗糖尿病和肥胖症的潜在疗法备受关注。从两株真菌中分离出六种varic酸类似物,并对其PTP1B抑制活性进行了评估。还通过分子建模对构效关系进行了表征和预测。进一步的动力学研究表明varic酸类似物具有可逆和竞争性抑制方式。三varic酸不仅在体外而且在体内均显示出胰岛素增敏作用,是一种有前景的先导化合物,有待进一步优化。